You are here

BMN-701

5 Things You Need to Know From BioMarin's R&D Day

Motley Fool

Thu, 09/19/13 - 03:09 am

BioMarin says it will continue studies of late-onset Pompe disease drug candidate BMN-701

Yahoo/AP

Wed, 03/20/13 - 12:26 pm

Piper Jaffray Boosts Target on BioMarin to $52 After Addition of BMN-701 to Model

Street Insider

Sun, 07/15/12 - 12:02 pm